XAIR Beyond Air Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: XAIR

Price (delayed)

$3.01

Market cap

$2.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$64

Enterprise value

$15.57M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 37
Relative Profitability: Rel. Profitability: 9

AIT Therapeutics Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts ...

Highlights
XAIR's gross profit has soared by 127% year-on-year and by 27% since the previous quarter
The company's gross margin has surged by 117% YoY and by 27% QoQ
The company's quick ratio rose by 47% YoY but it fell by 16% QoQ
The debt has soared by 102% year-on-year
Beyond Air's equity has shrunk by 80% YoY and by 67% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.beyondair.net
Peers: OFIX

Key stats

What are the main financial stats of XAIR

XAIR stock price

How has the Beyond Air stock price performed over time
Intraday
-5.94%
1 week
-2.27%
1 month
-40.28%
1 year
-93.48%
YTD
-79.27%
QTD
-66.26%

Financial performance

How have Beyond Air's revenue and profit performed over time
Revenue
$7.69M
Gross profit
$321,000
Operating income
-$28.04M
Net income
-$33.49M
Gross margin
4.2%
Net margin
-435.7%
XAIR's gross profit has soared by 127% year-on-year and by 27% since the previous quarter
The company's gross margin has surged by 117% YoY and by 27% QoQ
XAIR's revenue has surged by 61% year-on-year
Beyond Air's operating margin has surged by 55% YoY and by 3.5% QoQ

Price vs fundamentals

How does XAIR's price correlate with its fundamentals

Growth

What is Beyond Air's growth rate over time

Valuation

What is Beyond Air stock price valuation
P/E
N/A
P/B
1.09
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.03
XAIR's EPS has surged by 71% year-on-year and by 20% since the previous quarter
Beyond Air's equity has shrunk by 80% YoY and by 67% QoQ
The stock's price to book (P/B) is 57% less than its 5-year quarterly average of 2.7 and 23% less than its last 4 quarters average of 1.5
The price to sales (P/S) is 77% lower than the last 4 quarters average of 1.3
XAIR's revenue has surged by 61% year-on-year

Efficiency

How efficient is Beyond Air business performance
Beyond Air's ROE has plunged by 90% YoY and by 28% from the previous quarter
XAIR's return on sales has surged by 54% year-on-year and by 2.5% since the previous quarter
The company's return on invested capital rose by 43% YoY and by 8% QoQ
XAIR's return on assets is up by 15% year-on-year and by 2.8% since the previous quarter

Dividends

What is XAIR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XAIR.

Financial health

How did Beyond Air financials performed over time
The total assets is 9% more than the total liabilities
Beyond Air's total liabilities has surged by 70% YoY and by 3% QoQ
The company's quick ratio rose by 47% YoY but it fell by 16% QoQ
The debt has soared by 102% year-on-year
Beyond Air's equity has shrunk by 80% YoY and by 67% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.